US › Healthcare

Chemed Corp (CHE)

US · Healthcare · Medical Care Facilities

$539.72-0.16%
Last close · 2026-08-04

Latest quarter · ended 2026-06-30

Revenue
$673.3M
Revenue YoY
+8.8%
Net profit
$67.7M
Profit YoY
+29.0%
EPS
$5.52
EPS estimate
$5.12
Net margin
10.1%

EPS came in at 5.52 against a street estimate of 5.12 — a beat of 7.8%.

Key statistics

Market cap
$7.07B
P/E
26.7
Forward P/E
21.7
P/B
8.51
Book value
$64.15
EPS (TTM)
$19.91
Dividend yield
0.45%
52-week high
$551.68
52-week low
$364.71
50-day MA
$466.36
200-day MA
$435.92
Beta
0.52

Analyst view

Analysts rate Chemed Corp a strong buy (3 buy, 0 hold, 0 sell out of 3) with an average price target of $474.00.

Shareholding

Insiders
2.06%
Institutions
104.30%

Largest institutional holders

FundStake
Vanguard Group Inc11.09%
BlackRock Inc10.07%
Vanguard Portfolio Management, LLC6.14%
Vanguard Capital Management, LLC4.79%
JPMorgan Chase & Co3.77%
State Street Corp3.48%
AQR Capital Management LLC3.13%
Geode Capital Management, LLC3.10%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Chemed Corp — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.